United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis

A prospective phase II of daratumumab in previously treated systemic light chain amyloidosis (AL) patients

(2020) Murielle Roussel et al.   BLOOD

Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era

(2018) Arnt V. Kristen et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Outcomes after Cardiac Transplant for Wild Type Transthyretin Amyloidosis

(2018) Andrew N Rosenbaum et al.   TRANSPLANTATION

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

(2018) Mathew S. Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of Heart Transplantation for Transthyretin-Related Amyloid Cardiomyopathy

(2016) M. Sabatino et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

(2016) Mandeep R. Mehra et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Systemic amyloidosis

(2016) Ashutosh D Wechalekar et al.   LANCET

Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era

(2015) M. K. Davis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy

(2015) Margot K. Davis et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis

(2013) Lauren Gray Gilstrap et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS)

(2012) Frederick L. Ruberg et al.   AMERICAN HEART JOURNAL

Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy

(2012) Laerke M. Nelson et al.   CLINICAL TRANSPLANTATION

Heart transplantation and cardiac amyloidosis: Approach to screening and novel management strategies

(2011) Brandon C. Varr et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies

(2010) Joel Buxbaum et al.   AMERICAN HEART JOURNAL

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy (FAP): A single center experience

(2010) A. P. Barreiros et al.   LIVER TRANSPLANTATION

Progression of transthyretin amyloid neuropathy after liver transplantation

(2010) J. J. Liepnieks et al.   NEUROLOGY

Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis

(2009) Lawreen H. Connors et al.   AMERICAN HEART JOURNAL

Systemic Cardiac Amyloidoses

(2009) Claudio Rapezzi et al.   CIRCULATION

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE